EXOPULSE
Live / Applied — Final refusal mailed (as of 08 Oct 2025)
What this means for you
Not registered yet, but its 13 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79402456
- Mark type
- Stylized text
- Filed
- 13 May 2024
- Attorney of record
- Clifford D. Hyra
Goods and services
- Class 005 — Pharmaceuticals: Extracellular vesicles, namely, exosomes for medical use; extracellular vesicles for clinical use; biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications; living cells for medical purposes; pharmaceutical preparations and substances, namely, extracellular vesicles for treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, respiratory diseases, immunoregulatory disorders, metabolic disorders, infectious disorders, reproductive disorders, skin disorders, and hair loss disorders; dermatological preparations; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified extracellular vesicles for therapeutic use; pharmaceutical preparations, namely, extracellular vesicles to deliver protein or RNA for genetic therapy; extracellular vesicles for use in manufacture of pharmaceutical preparations; biological preparations for use in cell cultures for medical purposes; biological preparations comprising extracellular vesicles for medical purposes; biological preparations comprising a therapeutic target protein-loaded extracellular vesiclesfor medical purposes; biological preparations comprising extracellular vesicles for pharmaceutical purposes; biological reagents for medical use; medical preparations for treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, respiratory diseases, immunoregulatory disorders, metabolic disorders, infectious disorders, reproductive disorders, skin disorders, and hair loss disorders; none of the aforesaid products being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software
- Class 040 — Treatment of materials: Custom manufacturing of pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles, such as exosomes for therapeutic applications for others; custom manufacture services for others, namely, the rental of machines and apparatus for manufacturing pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles, such as exosomes for therapeutic applications; custom manufacturing consultancy with regard to aforementioned services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software
- Class 042 — Scientific and technological services: Contract new product research and contract new product development in the field of pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles, such as exosomes for therapeutic applications; biotechnological and medical research and product development; extracellular vesicles research and development for therapies; culturing of cells and tissues for others for scientific research purposes; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific research and analysis services in the field of extracellular vesicles; biological research; clinical research in the field of extracellular vesicles; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; scientific research in the nature of conducting clinical trials for others; scientific consultancy with regard to aforementioned services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software
Owner
Prosecution history
- 24 Oct 2025 — CORRECTION TRANSACTION RECEIVED FROM IB
- 08 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 08 Oct 2025 — FINAL REFUSAL E-MAILED
- 08 Oct 2025 — FINAL REFUSAL WRITTEN
- 09 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Feb 2025 — REFUSAL PROCESSED BY IB
- 10 Jan 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 10 Jan 2025 — REFUSAL PROCESSED BY MPU
- 19 Dec 2024 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 18 Dec 2024 — NON-FINAL ACTION WRITTEN
- 25 Nov 2024 — ASSIGNED TO EXAMINER
- 23 Aug 2024 — APPLICATION FILING RECEIPT MAILED
- 23 Aug 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED